Lancet Neurology study supports focused ultrasound on both sides of the brain for Parkinson's
In 54 patients, staged bilateral treatment improved core motor symptoms by 32% and motor complications by 67%, with benefits lasting over two years.
A multicenter study in The Lancet Neurology followed 54 people with Parkinson’s disease treated with MRI-guided focused ultrasound on both sides of the brain, one side at a time at least six months apart, using Insightec’s Exablate Neuro. Three months after the second treatment, core motor symptoms had improved 32% and motor complications 67%, with benefits lasting more than two years. Side effects were mostly mild to moderate, though speech and walking effects were more common after the second procedure.
The data support incision-free treatment as an alternative to deep brain stimulation for some patients.
Learn more: Focused ultrasound · Insightec